# Use of HA 330-II for Hemofiltration in Patients With ALF as a Bridge to Liver Transplantation .

> **NCT04243655** · PHASE4 · UNKNOWN · sponsor: **Asian Institute of Gastroenterology, India** · enrollment: 10 (estimated)

## Conditions studied

- Acute-On-Chronic Liver Failure

## Interventions

- **DEVICE:** HA 330-II
- **DRUG:** Standard medical treatment (SMT)

## Key facts

- **NCT ID:** NCT04243655
- **Lead sponsor:** Asian Institute of Gastroenterology, India
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-12-30
- **Primary completion:** 2020-10
- **Final completion:** 2020-12-31
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2020-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04243655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04243655, "Use of HA 330-II for Hemofiltration in Patients With ALF as a Bridge to Liver Transplantation .". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04243655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*